These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 7514247
1. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Leukemia; 1994 May; 8(5):823-6. PubMed ID: 7514247 [Abstract] [Full Text] [Related]
2. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia]. Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA. Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475 [Abstract] [Full Text] [Related]
3. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Syrjälä M, Anttila VJ, Ruutu T, Jansson SE. Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295 [Abstract] [Full Text] [Related]
4. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL). Solary E, Casasnovas RO, Campos L, Béné MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N. Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696 [Abstract] [Full Text] [Related]
5. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias. Ikushima S, Yoshihara T, Matsumura T, Misawa S, Morioka Y, Hibi S, Imashuku S. Int J Hematol; 1991 Oct; 54(5):395-403. PubMed ID: 1721853 [Abstract] [Full Text] [Related]
6. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Nishii K, Usui E, Katayama N, Lorenzo F, Nakase K, Kobayashi T, Miwa H, Mizutani M, Tanaka I, Nasu K, Dohy H, Kyo T, Taniwaki M, Ueda T, Kita K, Shiku H. Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630 [Abstract] [Full Text] [Related]
7. Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan. Chen SW, Li CF, Chuang SS, Tzeng CC, Hsieh YC, Lee PS, Chen CH, Huang WT, Hwang WS, Tsao CJ. Int J Lab Hematol; 2008 Apr; 30(2):133-8. PubMed ID: 18333845 [Abstract] [Full Text] [Related]
8. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study. Larramendy M, el-Rifai W, Saarinen U, Alitalo R, Luomahaara S, Knuutila S. Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947 [Abstract] [Full Text] [Related]
9. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Janossy G, Coustan-Smith E, Campana D. Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463 [Abstract] [Full Text] [Related]
10. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Chang H, Brandwein J, Yi QL, Chun K, Patterson B, Brien B. Leuk Res; 2004 Oct; 28(10):1007-11. PubMed ID: 15289011 [Abstract] [Full Text] [Related]
11. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML. Tien HF, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH. Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320 [Abstract] [Full Text] [Related]
12. Acute myeloid leukemia with concomitant expression of T-/B-lymphoid antigens and immunogenotypic alterations exhibiting t(7;12)(q32;q24). Kawakubo K, Ohyashiki K, Ohyashiki JH, Kuriyama Y, Iwabuchi A, Kimura N, Sugita K, Nakazawa S, Toyama K. Leukemia; 1993 Jun; 7(6):909-11. PubMed ID: 7684801 [Abstract] [Full Text] [Related]
13. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, Gong Q, Yao J, Li X, Du W, Huang S. Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959 [Abstract] [Full Text] [Related]
14. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21). Iriyama N, Hatta Y, Takeuchi J, Ogawa Y, Ohtake S, Sakura T, Mitani K, Ishida F, Takahashi M, Maeda T, Izumi T, Sakamaki H, Miyawaki S, Honda S, Miyazaki Y, Taki T, Taniwaki M, Naoe T. Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283 [Abstract] [Full Text] [Related]
15. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes. Liu YR, Zhu HH, Ruan GR, Qin YZ, Shi HX, Lai YY, Chang Y, Wang YZ, Lu D, Hao L, Li JL, Li LD, Jiang B, Huang XJ. Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747 [Abstract] [Full Text] [Related]
16. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD. Blood; 1994 Jul 01; 84(1):244-55. PubMed ID: 7517211 [Abstract] [Full Text] [Related]
20. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia. Soni M, Brody J, Allen SL, Schulman P, Kolitz J, Rai K, Broome JD, Koduru PR. Leukemia; 1996 Apr 01; 10(4):619-23. PubMed ID: 8618437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]